An isolated bispecific FN3 domain containing molecule comprising a first fibronectin type III domain and a second FN3 domain, wherein the first FN3 domain specifically binds epidermal growth factor receptor (EGFR) and blocks binding of epidermal growth factor to EGFR, and the second FN3 domain specifically binds hepatocyte growth factor receptor (c-Met) and blocks binding of hepatocyte growth factor to c-Met, wherein the first FN3 domain comprises: (a) an FG loop comprising the sequence HNVYKDTNX 9 RGL (SEQ ID NO: 179) or the sequence LGSYVFEHDVML (SEQ ID NO: 180), wherein X 9 is M or I; and (b) a BC loop comprising the sequence X 1 X 2 X 3 X 4 X 5 X 6 X 7 X 8 (SEQ ID NO: 181), wherein X 1 is A, T, G or D; X 2 is A, D, Y or W; X 3 is P, D or N; X 4 is L or absent; X 5 is D, H, R, G, Y or W; X 6 is G, D or A; X 7 is A, F, G, H or D; and X 8 is Y, F or L; and and wherein the second FN3 domain comprises: (a) a C strand and a CD loop comprising the sequence DSFX 10 IRYX 11 E X 12 X 13 X 14 X 15 GX 16 (SEQ ID NO: 184), wherein X 10 is W, F or V; X 11 is D, F or L; X 12 is V, F or L; X 13 is V, L or T; X 14 is V, R, G, L, Tor S; X 15 is G, S, A, T or K; and X 16 is E or D; and (b) a F strand and a FG loop comprising the sequence TEYX 17 VX 18 IX 19 X 20 V KGGX 21 X 22 SX 23 (SEQ ID NO: 185), wherein X 17 is Y, W, I, V, G or A; X 18 is N, T, Q or G; X 19 is L, M, N or I; X 20 is G or S; X 21 is S, L, G, Y, T, R, H or K; X 22 is I, V or L; and X 23 is V, T, H, I, P, Yor L. wherein the first FN3 domain comprises: (a) an FG loop comprising the sequence HNVYKDTNX 9 RGL (SEQ ID NO: 179) or the sequence LGSYVFEHDVML (SEQ ID NO: 180), wherein X 9 is M or I; and (b) a BC loop comprising the sequence X 1 X 2 X 3 X 4 X 5 X 6 X 7 X 8 (SEQ ID NO: 181), wherein X 1 is A, T, G or D; X 2 is A, D, Y or W; X 3 is P, D or N; X 4 is L or absent; X 5 is D, H, R, G, Y or W; X 6 is G, D or A; X 7 is A, F, G, H or D; and X 8 is Y, F or L; and (a) an FG loop comprising the sequence HNVYKDTNX 9 RGL (SEQ ID NO: 179) or the sequence LGSYVFEHDVML (SEQ ID NO: 180), wherein X 9 is M or I; and (b) a BC loop comprising the sequence X 1 X 2 X 3 X 4 X 5 X 6 X 7 X 8 (SEQ ID NO: 181), wherein X 1 is A, T, G or D; X 2 is A, D, Y or W; X 3 is P, D or N; X 4 is L or absent; X 5 is D, H, R, G, Y or W; X 6 is G, D or A; X 7 is A, F, G, H or D; and X 8 is Y, F or L; and X 1 is A, T, G or D; X 2 is A, D, Y or W; X 3 is P, D or N; X 4 is L or absent; X 5 is D, H, R, G, Y or W; X 6 is G, D or A; X 7 is A, F, G, H or D; and X 8 is Y, F or L; and and wherein the second FN3 domain comprises: (a) a C strand and a CD loop comprising the sequence DSFX 10 IRYX 11 E X 12 X 13 X 14 X 15 GX 16 (SEQ ID NO: 184), wherein X 10 is W, F or V; X 11 is D, F or L; X 12 is V, F or L; X 13 is V, L or T; X 14 is V, R, G, L, Tor S; X 15 is G, S, A, T or K; and X 16 is E or D; and (b) a F strand and a FG loop comprising the sequence TEYX 17 VX 18 IX 19 X 20 V KGGX 21 X 22 SX 23 (SEQ ID NO: 185), wherein X 17 is Y, W, I, V, G or A; X 18 is N, T, Q or G; X 19 is L, M, N or I; X 20 is G or S; X 21 is S, L, G, Y, T, R, H or K; X 22 is I, V or L; and X 23 is V, T, H, I, P, Yor L. (a) a C strand and a CD loop comprising the sequence DSFX 10 IRYX 11 E X 12 X 13 X 14 X 15 GX 16 (SEQ ID NO: 184), wherein X 10 is W, F or V; X 11 is D, F or L; X 12 is V, F or L; X 13 is V, L or T; X 14 is V, R, G, L, Tor S; X 15 is G, S, A, T or K; and X 16 is E or D; and X 10 is W, F or V; X 11 is D, F or L; X 12 is V, F or L; X 13 is V, L or T; X 14 is V, R, G, L, Tor S; X 15 is G, S, A, T or K; and X 16 is E or D; and (b) a F strand and a FG loop comprising the sequence TEYX 17 VX 18 IX 19 X 20 V KGGX 21 X 22 SX 23 (SEQ ID NO: 185), wherein X 17 is Y, W, I, V, G or A; X 18 is N, T, Q or G; X 19 is L, M, N or I; X 20 is G or S; X 21 is S, L, G, Y, T, R, H or K; X 22 is I, V or L; and X 23 is V, T, H, I, P, Yor L. X 17 is Y, W, I, V, G or A; X 18 is N, T, Q or G; X 19 is L, M, N or I; X 20 is G or S; X 21 is S, L, G, Y, T, R, H or K; X 22 is I, V or L; and X 23 is V, T, H, I, P, Yor L.